1-9 of 9
Louise Smith
Close
Sort by
Journal Articles

Minimising Transfusion Therapy and Alloimmunisation in Patients with Sickle Cell Disorder in the Era of Hydroxyurea

Louise Smith, RCN MSc, Lucy Stead, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 5078.
https://doi.org/10.1182/blood-2018-99-119837
Published: 2018
Journal Articles

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Louise Smith, RCN MSc, Elizabeth Ryan, MB ChB, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 4927.
https://doi.org/10.1182/blood-2018-99-119768
Published: 2018
Journal Articles

Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell Disorders

Indrani Karpha, MPhil, MRCP, MBBS, Louise Smith, RCN MSc, Lawrence Abernathy, FRCR, Kate LE Phillips, PhD, Russell D Keenan, MBChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 977.
https://doi.org/10.1182/blood.V130.Suppl_1.977.977
Published: 2017
Journal Articles

Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease

Louise Smith, RCN MSc, Amy Littler, RCN, Kate LE Phillips, PhD, Russell D Keenan, MBChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 3546.
https://doi.org/10.1182/blood.V130.Suppl_1.3546.3546
Published: 2017
Journal Articles

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Elizabeth A Jones, MB ChB MRCPCH FRCPath, Louise Smith, RCN MSc, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 4595.
https://doi.org/10.1182/blood.V126.23.4595.4595
Published: 2015
Journal Articles

Hydroxyurea Therapy for Sickle Cell Disorders in Childhood: Adherence to Therapy Transforms Lives and Needs to be the Focus - the Experience of Alder Hey Children's Hospital

Louise Smith, RCN MSc, Kate L E Phillips, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 990.
https://doi.org/10.1182/blood.V126.23.990.990
Published: 2015
Journal Articles

CD62L Expression Is Associated With Chronic Lymphocytic Leukemia (CLL) Cell Survival In Vitro and Represents a Novel Therapeutic Target In CLL

Melinda Burgess, Peter Mollee, Richa Singhania, Catherine Cheung, Lynne Chambers, Reynolds Brent, Louise Smith, Nicholas Saunders, Nigel McMillan, Devinder S Gill
Journal: Blood
Blood (2013) 122 (21): 4136.
https://doi.org/10.1182/blood.V122.21.4136.4136
Published: 2013
Journal Articles

Tyrosine-Dependent and -Independent Mechanisms of STAT3 Activation by the Human Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Differentially Utilized Depending on G-CSF Concentration

Alister C. Ward, Mirjam H.A. Hermans, Louise Smith, Yvette M. van Aesch, Anita M. Schelen, Claudia Antonissen, Ivo P. Touw
Journal: Blood
Blood (1999) 93 (1): 113–124.
https://doi.org/10.1182/blood.V93.1.113
Published: 1999
Journal Articles

Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor

John P. de Koning, Amrita A. Soede-Bobok, Anita M. Schelen, Louise Smith, Daphne van Leeuwen, Valeria Santini, Boudewijn M.T. Burgering, Johannes L. Bos, Bob Löwenberg, Ivo P. Touw
Journal: Blood
Blood (1998) 91 (6): 1924–1933.
https://doi.org/10.1182/blood.V91.6.1924
Published: 1998